Omega Healthcare Investors (NYSE:OHI – Get Free Report) had its price target cut by analysts at Truist Financial from $34.00 to $31.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price objective suggests a potential upside of 0.98% from the company’s previous close.
A number of other research analysts have also issued reports on the stock. Raymond James boosted their price target on shares of Omega Healthcare Investors from $33.00 to $36.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 20th. Jefferies Financial Group increased their target price on Omega Healthcare Investors from $28.00 to $33.00 in a research note on Wednesday, September 20th. Mizuho upgraded Omega Healthcare Investors from a “neutral” rating to a “buy” rating and lifted their price target for the company from $31.00 to $35.00 in a research note on Friday, September 8th. BNP Paribas cut Omega Healthcare Investors from a “neutral” rating to an “underperform” rating in a research report on Monday, November 6th. Finally, Wells Fargo & Company reduced their target price on Omega Healthcare Investors from $34.00 to $33.00 and set an “equal weight” rating for the company in a report on Monday, November 27th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $32.61.
Get Our Latest Research Report on OHI
Omega Healthcare Investors Price Performance
Shares of NYSE:OHI opened at $30.70 on Tuesday. The company has a 50-day simple moving average of $31.87 and a 200-day simple moving average of $31.89. Omega Healthcare Investors has a one year low of $25.61 and a one year high of $34.77. The company has a debt-to-equity ratio of 1.37, a quick ratio of 6.99 and a current ratio of 6.99. The stock has a market capitalization of $7.52 billion, a price-to-earnings ratio of 31.98 and a beta of 0.93.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in OHI. Federated Hermes Inc. raised its stake in shares of Omega Healthcare Investors by 7,010.8% during the 1st quarter. Federated Hermes Inc. now owns 2,482,964 shares of the real estate investment trust’s stock worth $77,369,000 after buying an additional 2,448,046 shares during the last quarter. State Street Corp raised its stake in shares of Omega Healthcare Investors by 14.8% during the 1st quarter. State Street Corp now owns 13,300,467 shares of the real estate investment trust’s stock worth $414,443,000 after buying an additional 1,715,004 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich acquired a new position in shares of Omega Healthcare Investors during the 2nd quarter worth $51,212,000. Marshall Wace LLP raised its stake in shares of Omega Healthcare Investors by 150.5% during the 2nd quarter. Marshall Wace LLP now owns 2,731,979 shares of the real estate investment trust’s stock worth $83,844,000 after buying an additional 1,641,488 shares during the last quarter. Finally, FMR LLC raised its stake in Omega Healthcare Investors by 96.5% in the 3rd quarter. FMR LLC now owns 2,982,743 shares of the real estate investment trust’s stock valued at $98,908,000 after purchasing an additional 1,464,693 shares during the last quarter. Institutional investors and hedge funds own 65.50% of the company’s stock.
Omega Healthcare Investors Company Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
See Also
NYSE: OHI‘ width=’650′ height=’330’ />
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Omega Healthcare Investors wasn’t on the list.
While Omega Healthcare Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Click the link below and we’ll send you MarketBeat’s guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Source: marketbeat.com
